Attana introduces Attana Virus Analytics to support global COVID-19 testing efforts
Since the advent of the COVID-19 outbreak Attana has been engaged by select customers to assist in their development of novel vaccine candidates and potential virus treatments. In these efforts, Attana instruments have routinely been used to analyze serum samples in real time, generating in-depth data of both virus and antibody presence. Given the strong global demand for COVID-19 testing and in particular, accurate antibody testing, Attana has introduced Attana Virus Analytics (AVA) and commenced discussions with various potential customers including international government entities